MCLEAN, Va. -- (BUSINESS WIRE) -- Alion Science and Technology, a global engineering, R&D, IT and operational solutions company, has won a $11.4 million Defense Threat Reduction Agency (DTRA) contract to develop an integrated set of chemical, biological, radiological, nuclear and high-yield explosives (CBRNE) modeling and simulation tools to support Counter Weapons of Mass Destruction (CWMD) mission operational support, analysis and training.
Under the contract, Alion will make enhancements to the Force-on-Force Evaluation and Analysis of Key Performance Parameters (FREAK) toolset by modernizing and managing code and software development, software production and distribution. FREAK is a comprehensive solution that supports training, security analysis and investment decision support related to weapons of mass destruction (WMD). The system can accurately model the most challenging WMD situations.
“FREAK provides operational support to CBRNE missions as well as training in wide area search missions and analysis on physical security and personnel recovery,” said Terri Spoonhour, Alion Senior Vice President and Distributed Simulation Group Manager. “Alion’s years of Joint Semi-Automated Forces (JSAF) code development and configuration management experience, coupled with a vast understanding of the Counter Weapons of Mass Destruction (CWMD) mission space, are the keys to our ability to enhance the FREAK architecture. Ultimately, this means better training support for our warfighters and faster responses to real-world threats.”
About Alion Science and Technology
Alion Science and Technology delivers advanced engineering, IT and operational solutions to strengthen national security and drive business results. For customers in defense, civilian government and commercial industries, Alion’s engineered solutions support smarter decision-making and enhanced readiness in rapidly changing environments. Building on over 75 years of innovation, Alion turns obstacles into opportunities to help customers achieve their missions. For more information, visit www.alionscience.com.
This press release contains information about management’s view of Alion’s future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of a variety of risk factors and uncertainties discussed in documents periodically filed by Alion with the SEC. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.